Amedisys Stock Today
| AMED Stock | USD 91.23 0.21 0.23% |
Performance0 of 100
| Odds Of DistressLess than 10
|
Amedisys is trading at 91.23 as of the 28th of November 2024, a 0.23 percent increase since the beginning of the trading day. The stock's lowest day price was 90.91. Amedisys has less than a 10 % chance of experiencing some financial distress in the next two years of operation, but has generated negative returns over the last 90 days. Equity ratings for Amedisys are calculated daily based on our scoring framework. The performance scores are derived for the period starting the 29th of October 2024 and ending today, the 28th of November 2024. Click here to learn more.
Business Domain Health Care Equipment & Services | IPO Date 17th of August 1994 | Category Healthcare | Classification Health Care |
Amedisys, Inc., together with its subsidiaries, provides healthcare services in the United States. Amedisys, Inc. was incorporated in 1982 and is headquartered in Baton Rouge, Louisiana. Amedisys operates under Medical Care Facilities classification in the United States and is traded on NASDAQ Exchange. The company has 32.75 M outstanding shares of which 2.18 M shares are presently shorted by private and institutional investors with about 3.78 trading days to cover. More on Amedisys
Moving against Amedisys Stock
Follow Valuation Profit Patterns Odds of Bankruptcy
Check how we calculate scores
Amedisys Stock Highlights
ESG Sustainability
Environmental | Governance | Social |
| CEO President | Richard Ashworth | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Old Name | Amedeo Resources Plc | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Business Concentration | Health Care Providers & Services, Health Care Equipment & Services, Health Care, NASDAQ Composite, SP Midcap 400, Health Care, Health Care Providers & Services, Medical Care Facilities, Healthcare (View all Sectors) | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Average Analyst Recommendation | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Financial Strength
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Debt LevelsAmedisys can leverage the use of borrowed funds to amplify returns from an investment. In general, analyzing the relationship between debt to total assets helps investors to understand Amedisys' financial leverage. It provides some insight into what part of Amedisys' total assets is financed by creditors.
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Amedisys (AMED) is traded on NASDAQ Exchange in USA. It is located in 3854 American Way, Baton Rouge, LA, United States, 70816 and employs 19,000 people. Amedisys is listed under Health Care Providers & Services category by Fama And French industry classification. The company currently falls under 'Mid-Cap' category with a current market capitalization of 2.99 B. Amedisys conducts business under Health Care Providers & Services sector and is part of Health Care industry. The entity has 32.75 M outstanding shares of which 2.18 M shares are presently shorted by private and institutional investors with about 3.78 trading days to cover.
Amedisys currently holds about 17.96 M in cash with 137.19 M of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 0.55.
Check Amedisys Probability Of Bankruptcy
Ownership AllocationAmedisys holds a total of 32.75 Million outstanding shares. The majority of Amedisys outstanding shares are owned by other corporate entities. These outside corporations are usually referred to as non-private investors looking to acquire positions in Amedisys to benefit from reduced commissions. Consequently, institutional investors are subject to a different set of regulations than regular investors in Amedisys. Please pay attention to any change in the institutional holdings of Amedisys as this could imply that something significant has changed or is about to change at the company. Please note that no matter how many assets the company secures, if the real value of the firm is less than the current market value, you may not be able to make money on it.
Check Amedisys Ownership Details
Amedisys Stock Institutional Holders
| Instituion | Recorded On | Shares | |
| Mackenzie Investments | 2024-09-30 | 694.6 K | |
| Magnetar Financial Llc | 2024-09-30 | 635.6 K | |
| Citadel Advisors Llc | 2024-09-30 | 604.3 K | |
| Geode Capital Management, Llc | 2024-09-30 | 567.1 K | |
| Dimensional Fund Advisors, Inc. | 2024-09-30 | 509.3 K | |
| Balyasny Asset Management Llc | 2024-09-30 | 474.3 K | |
| Cresset Asset Management, Llc | 2024-09-30 | 458.4 K | |
| Sand Grove Capital Management Llp | 2024-06-30 | 435.1 K | |
| Qube Research & Technologies | 2024-06-30 | 412.3 K | |
| Vanguard Group Inc | 2024-09-30 | 3.2 M | |
| Blackrock Inc | 2024-06-30 | 3.1 M |
Amedisys Historical Income Statement
Amedisys Stock Against Markets
Amedisys Corporate Management
| John Nugent | Chief Officer | Profile | |
| Pete Hartley | CTO Systems | Profile | |
| Kendra Kimmons | VP Relations | Profile | |
| Jennifer Griffin | Deputy VP | Profile | |
| Janet Britt | VP Collections | Profile | |
| Francis Mayer | Senior Development | Profile |
Already Invested in Amedisys?
The danger of trading Amedisys is mainly related to its market volatility and Company specific events. As an investor, you must understand the concept of risk-adjusted return before you start trading. The most common way to measure the risk of Amedisys is by using the Sharpe ratio. The ratio expresses how much excess return you acquire for the extra volatility you endure for holding a more risker asset than Amedisys. The Sharpe ratio is calculated by using standard deviation and excess return to determine reward per unit of risk. To understand how volatile Amedisys is, you must compare it to a benchmark. Traditionally, the risk-free rate of return is the rate of return on the shortest-dated U.S. Treasury, such as a 3-year bond.
When determining whether Amedisys is a strong investment it is important to analyze Amedisys' competitive position within its industry, examining market share, product or service uniqueness, and competitive advantages. Beyond financials and market position, potential investors should also consider broader economic conditions, industry trends, and any regulatory or geopolitical factors that may impact Amedisys' future performance. For an informed investment choice regarding Amedisys Stock, refer to the following important reports: Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Amedisys. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in income. For information on how to trade Amedisys Stock refer to our How to Trade Amedisys Stock guide.You can also try the Money Flow Index module to determine momentum by analyzing Money Flow Index and other technical indicators.
Is Health Care Providers & Services space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Amedisys. If investors know Amedisys will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Amedisys listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth (0.35) | Earnings Share 2.52 | Revenue Per Share 71.004 | Quarterly Revenue Growth 0.057 | Return On Assets 0.0627 |
The market value of Amedisys is measured differently than its book value, which is the value of Amedisys that is recorded on the company's balance sheet. Investors also form their own opinion of Amedisys' value that differs from its market value or its book value, called intrinsic value, which is Amedisys' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Amedisys' market value can be influenced by many factors that don't directly affect Amedisys' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Amedisys' value and its price as these two are different measures arrived at by different means. Investors typically determine if Amedisys is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Amedisys' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.